TP53 and neoplasm: In addition to the expression of SA‐β‐Gal, we found that SCT treatment dramatically promoted expression of cell cycle regulatory molecules P53, P21, and P16, as well as increased expression of genes encoding proinflammatory cytokines, including interleukin 1beta, 6, 8 (IL‐1β, IL‐6, IL‐8), and tumor necrosis factor alpha (TNFα), in tumor cells (Figure S4A,B, Supporting Information).